Filing Details

Accession Number:
0000899243-21-000430
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-05 17:40:46
Reporting Period:
2021-01-04
Accepted Time:
2021-01-05 17:40:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1745999 Beam Therapeutics Inc. BEAM Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786484 Terry-Ann Burrell C/O Beam Therapeutics Inc.
26 Landsdowne Street
Cambridge MA 02139
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-04 25,000 $13.68 32,309 No 4 M Direct
Common Stock Disposition 2021-01-04 800 $78.05 31,509 No 4 S Direct
Common Stock Disposition 2021-01-04 1,951 $79.21 29,558 No 4 S Direct
Common Stock Disposition 2021-01-04 2,449 $80.25 27,109 No 4 S Direct
Common Stock Disposition 2021-01-04 6,509 $81.26 20,600 No 4 S Direct
Common Stock Disposition 2021-01-04 5,296 $82.44 15,304 No 4 S Direct
Common Stock Disposition 2021-01-04 7,095 $83.15 8,209 No 4 S Direct
Common Stock Disposition 2021-01-04 900 $83.89 7,309 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-04 25,000 $0.00 25,000 $13.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
357,941 2029-08-31 No 4 M Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. 25% of the shares subject to the stock option vested on the first anniversary of the of the vesting commencement date, August 20, 2019, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with BEAM through such dates.
  3. These shares were sold in multiple transactions ranging from $77.65 to $78.48 inclusive.
  4. These shares were sold in multiple transactions ranging from $78.72 to $79.65 inclusive.
  5. These shares were sold in multiple transactions ranging from $79.73 to $80.72 inclusive.
  6. These shares were sold in multiple transactions ranging from $80.73 to $81.72 inclusive.
  7. These shares were sold in multiple transactions ranging from $81.80 to $82.79 inclusive.
  8. These shares were sold in multiple transactions ranging from $82.80 to $83.78 inclusive.
  9. These shares were sold in multiple transactions ranging from $83.85 to $84.01 inclusive.